This inventor holds 9 USPTO granted patents. Top assignees: Sumitomo Chemical Company, Limited, Nitto-Denko Corporation, Yamanouchi Pharmaceutical Company Ltd.. Active years: 1981-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (1986)
- Ibaraki, JP (1981 - 1997)
Company Filing History:

Years Active: 1981-2026
Title: The Innovative Contributions of Makoto Nakamura
Introduction
Makoto Nakamura is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of chemistry, particularly in the development of various chemical compounds. With a total of 9 patents to his name, Nakamura's work has had a notable impact on the pharmaceutical industry.
Latest Patents
Nakamura's latest patents include a crystal form of benzodiazepine derivatives and a process for the preparation of hydroxybenzaldehydes. In a Reimer-Tiemann reaction for the preparation of a mixture of two hydroxybenzaldehydes, namely salicylaldehyde and p-hydroxybenzaldehyde, he has developed a method that allows for controlled formation ratios, yields, and reaction rates. This is achieved by reacting phenol with chloroform and an aqueous alkali solution in a heterogeneous system, utilizing a phase transfer catalyst selected from cationic, amphoteric, and anionic types.
Career Highlights
Throughout his career, Nakamura has worked with notable companies such as Sumitomo Chemical Company, Limited and Yamanouchi Pharmaceutical Company Ltd. His expertise in chemical processes and innovations has made him a valuable asset in these organizations.
Collaborations
Nakamura has collaborated with esteemed colleagues, including Tsutomu Chiyoda and Shinichi Hasegawa. These partnerships have further enhanced his research and development efforts in the field of chemistry.
Conclusion
Makoto Nakamura's contributions to the field of chemistry through his patents and collaborations highlight his innovative spirit and dedication to advancing chemical science. His work continues to influence the pharmaceutical industry and inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile